Form 4: Director Michael J. Barber Receives RSU Grant at XRAY

Dentsply Sirona director Michael J. Barber was granted 22,822 restricted stock units as part of annual compensation.

Summary

• Director Michael J. Barber acquired 22,822 restricted stock units (RSUs) of Dentsply Sirona Inc. (XRAY).
• The transaction occurred on June 3, 2026.
• The RSUs were granted at a price of $0, representing equity-based compensation.
• Following this transaction, the director's total beneficial ownership increased to 40,768 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which carries a neutral sentiment.

Positives

• The grant aligns the director's interests with long-term shareholder value through equity ownership.

Negatives

• None identified.

Risks

• The value of the equity grant is subject to market volatility and the future performance of Dentsply Sirona stock.

Future Outlook

The RSUs are scheduled to vest in full one year from the date of the grant, on June 3, 2027.

Industry Context

StockSavvy.ai notes that equity-based compensation for board members is a standard corporate governance practice in the medical technology sector to ensure alignment with shareholder interests.

Comparison to Industry Standards

• The use of RSUs as a component of director compensation is consistent with standard practices among S&P 500 and mid-cap healthcare companies.
• The one-year vesting period is a common retention and alignment mechanism for non-employee directors.

Stakeholder Impact

• Shareholders may view the increased equity stake of a director as a positive sign of confidence in the company's long-term prospects.

Next Steps

• The RSUs will vest on June 3, 2027.

Key Dates

Keywords

Dentsply Sirona, XRAY, Form 4, Insider Trading, Restricted Stock Units, Director Compensation